Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial

by Jagdeep Nanchahal, Catherine Ball, Dominique Davidson, Lynn Williams, William Sones, Fiona E. McCann, Marisa Cabrita, Jennifer Swettenham, Neil J. Cahoon, Bethan Copsey, E. Anne Francis, Peter C. Taylor, Joanna Black, Vicki S. Barber, Susan Dutton, Marc Feldmann, Sarah E. Lamb
Published 2018-07-01